Indian medical startup CORE Diagnostics has entered into a new partnership with leading US-based molecular diagnostics company Paradigm to bring to India the latter’s advanced cancer profiling service, PCDx, which helps in detailed personalizing of each cancer patient’s course of treatment.
![logo](https://corediagnostics.in/wp-content/uploads/2022/11/Logo_CORE_White-uai-258x99-1-1.png)